Rimactan 300 mg Norwegen - Norwegisch - Statens legemiddelverk

rimactan 300 mg

orifarm as - rifampicin - kapsel, hard - 300 mg

Vinorelbine Orifarm 30 mg Norwegen - Norwegisch - Statens legemiddelverk

vinorelbine orifarm 30 mg

orifarm generics a/s - vinorelbintartrat - kapsel, myk - 30 mg

Vinorelbine Orifarm 20 mg Norwegen - Norwegisch - Statens legemiddelverk

vinorelbine orifarm 20 mg

orifarm generics a/s - vinorelbintartrat - kapsel, myk - 20 mg

Kapruvia Europäische Union - Norwegisch - EMA (European Medicines Agency)

kapruvia

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - alle andre terapeutiske produkter - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Amodip 1.25 mg Norwegen - Norwegisch - Statens legemiddelverk

amodip 1.25 mg

ceva santé animale - amlodipinbesilat - tyggetablett - 1.25 mg

Tibsovo Europäische Union - Norwegisch - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.